结核菌病毒S调节器的晶体结构揭示了其与化合物SMARt751的相互作用
Camille Grosse1, Maud Sigoillot2, Véronique Megalizzi2
1Unit of Microbiology, Bioorganic and Macromolecular Chemistry, Department of Research in Drug Development, Faculty of Pharmacy, Université Libre de Bruxelles, Belgium; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.
Journal of structural biology
|March 28, 2024
概括
研究人员阐明了VirS的晶体结构,VirS是结核病治疗中以胺胺激活的调节剂. 这一发现揭示了SMARt751如何与Virus结合,为新的结核病疗法铺平了道路.
科学领域:
- 结构生物学 结构生物学
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
背景情况:
- 埃塞奥纳米德 (ETO) 是结核病治疗的关键二线药物.
- 单氧基酶MymA激活ETO,其表达由调节器VirS控制.
- 提升MymA表达的VirS配体提供了针对结核病的新治疗策略.
研究的目的:
- 为了确定AraC类调节器VirS的晶体结构,与潜在的治疗性SMARt751.1.相结合.
- 在原子层面上了解SMARt751和VirS之间的结合相互作用.
- 分析SMARt751对VirS监管功能的结构影响.
主要方法:
- 进行X射线晶体学,以获得与SMARt751.1.相结合的VirS的晶体结构.
- 结构改进至1.69 Å的分辨率.
- 在现场蛋白解法用于晶体形成.
- 在 AraC 转录调节器家族内的结构比较.
主要成果:
- 确定了与SMARt751复合的VirS联体结合域的第一个晶体结构.
- SMARt751 结合在 VirS 中的疏水性腔内,形成特定的和范德瓦尔斯相互作用.
- 该结构为SMARt751.1.的VirS监管机制提供了洞察力.
结论:
- 阐明的结构为理解 VirS-SMARt751 相互作用提供了分子基础.
- 这些结构信息对于合理设计针对结核病的新药至关重要.
- 这些发现支持调节VirS活动的治疗策略,以提高埃西奥纳米德的疗效.
相关概念视频
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...


